FDA v. Alliance for Hippocratic Medicine

Summary

The Supreme Court held that the pro‑life doctors and medical associations lack Article III standing to challenge the FDA's 2016 and 2021 regulatory changes to mifepristone, and therefore reversed the Fifth Circuit and remanded for further proceedings.